During the last session, GoodRx Holdings Inc. (NASDAQ:GDRX)’s traded shares were 1.64 million. At the end of the trading day, the stock’s price was $38.33, reflecting an intraday loss of -1.89% or -$0.74. The 52-week high for the GDRX share is $64.22, that puts it down -67.55 from that peak though still a striking 30.45% gain since the share price plummeted to a 52-week low of $26.66. The company’s market capitalization is $15.17B, and the average intraday trading volume over the past 10 days was 1.57 million shares, and the average trade volume was 2.42 million shares over the past three months.
GoodRx Holdings Inc. (GDRX) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.30. GDRX has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 6 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 8 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.08.
GoodRx Holdings Inc. (NASDAQ:GDRX) trade information
GoodRx Holdings Inc. (GDRX) registered a -1.89% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.89% in intraday trading to $38.33 this Wednesday, 06/09/21, hitting a weekly high. The stock’s 5-day price performance is -2.99%, and it has moved by 21.88% in 30 days. The short interest in GoodRx Holdings Inc. (NASDAQ:GDRX) is 16.46 million shares and it means that shorts have 8.66 day(s) to cover.
The consensus price target of analysts on Wall Street is $42.07, which implies an increase of 8.89% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $27.00 and $56.00 respectively. As a result, GDRX is trading at a discount of -46.1% off the target high and 29.56% off the low.
GoodRx Holdings Inc. (GDRX) estimates and forecasts
Statistics show that GoodRx Holdings Inc. has underperformed its competitors in share price, compared to the industry in which it operates. GoodRx Holdings Inc. (GDRX) shares have gone up 1.16% during the last six months, with a year-to-date growth rate less than the industry average at 8.82% against 14.80. In the rating firms’ projections, revenue will increase 36.00% compared to the previous financial year.
Revenue for the current quarter is expected to be $174.56 million as predicted by 12 analyst(s). Meanwhile, a consensus of 12 analyst(s) estimates revenue growth to $195.28 million by the end of Sep 2021.
While earnings are projected to return -720.20% in 2021, the next five years will return 33.23% per annum.
GoodRx Holdings Inc. is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
GoodRx Holdings Inc. (NASDAQ:GDRX)’s Major holders
GoodRx Holdings Inc. insiders own 9.16% of total outstanding shares while institutional holders control 69.89%, with the float percentage being 76.94%. Wellington Management Group, LLP is the largest shareholder of the company, while 239 institutions own stock in it. As of Mar 30, 2021, the company held over 4.54 million shares (or 6.53% of all shares), a total value of $177.25 million in shares.
The next largest institutional holding, with 3.56 million shares, is of Morgan Stanley’s that is approximately 5.12% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $138.93 million.
Also, the Mutual Funds coming in first place with the largest holdings of GoodRx Holdings Inc. (GDRX) shares are Morgan Stanley Inst Fund Tr-Discovery Port and Vanguard Total Stock Market Index Fund. Data provided on Mar 30, 2021 indicates that Morgan Stanley Inst Fund Tr-Discovery Port owns about 1.31 million shares. This amounts to just over 1.89 percent of the company’s overall shares, with a $51.16 million market value. The same data shows that the other fund manager holds slightly less at 1.1 million, or about 1.58% of the stock, which is worth about $42.82 million.